Skip to content

Food and Drugs Act

R.S.C., 1985, c. F-27

In forceCurrent to September 30, 2026 History

Follow

Part I — Foods, Drugs, Cosmetics and Devices

Advanced Therapeutic Products

Section 21.93

Marginal note:Suspension and revocation

  •  (1) Subject to the regulations, the Minister may suspend or revoke an advanced therapeutic product licence, in whole or in part, if

    • (a) the Minister believes that the risks that are associated with the advanced therapeutic product outweigh the benefits;

    • (b) the Minister believes that the risks associated with the product or any authorized activity are not being adequately managed or controlled;

    • (c) in the case of a suspension, any prescribed circumstance exists; or

    • (d) in the case of a revocation, any prescribed circumstance exists.

  • Marginal note:Suspension without prior notice

    (2) If the Minister believes that an immediate suspension is necessary to prevent injury to health, the Minister may suspend an advanced therapeutic product licence, in whole or in part, without prior notice to its holder and regardless of whether any of the circumstances referred to in subsection (1) exists.

  • 2019, c. 29, s. 169
.

Version in force since June 21, 2019

Unofficial reproduction of the consolidated text published by the Department of Justice Canada, permitted by the Reproduction of Federal Law Order. Only the official text is authoritative.